234 related articles for article (PubMed ID: 24953650)
1. Sox2 cooperates with Lkb1 loss in a mouse model of squamous cell lung cancer.
Mukhopadhyay A; Berrett KC; Kc U; Clair PM; Pop SM; Carr SR; Witt BL; Oliver TG
Cell Rep; 2014 Jul; 8(1):40-9. PubMed ID: 24953650
[TBL] [Abstract][Full Text] [Related]
2. Dysregulated Tgfbr2/ERK-Smad4/SOX2 Signaling Promotes Lung Squamous Cell Carcinoma Formation.
Wang Y; Tan X; Tang Y; Zhang C; Xu J; Zhou J; Cheng X; Hou N; Liu W; Yang G; Teng Y; Yang X
Cancer Res; 2019 Sep; 79(17):4466-4479. PubMed ID: 31209059
[TBL] [Abstract][Full Text] [Related]
3. SOX2 in squamous cell carcinoma: amplifying a pleiotropic oncogene along carcinogenesis.
Hussenet T; du Manoir S
Cell Cycle; 2010 Apr; 9(8):1480-6. PubMed ID: 20372069
[TBL] [Abstract][Full Text] [Related]
4. Sex-Determining Region Y-box 2 Promotes Growth of Lung Squamous Cell Carcinoma and Directly Targets Cyclin D1.
Li C; He B; Huang C; Yang H; Cao L; Huang J; Hu C
DNA Cell Biol; 2017 Apr; 36(4):264-272. PubMed ID: 28151013
[TBL] [Abstract][Full Text] [Related]
5. A subtype of oral, laryngeal, esophageal, and lung, squamous cell carcinoma with high levels of TrkB-T1 neurotrophin receptor mRNA.
Zhou Y; Sinha S; Schwartz JL; Adami GR
BMC Cancer; 2019 Jun; 19(1):607. PubMed ID: 31221127
[TBL] [Abstract][Full Text] [Related]
6. Sex determining region Y-Box 2 (SOX2) is a potential cell-lineage gene highly expressed in the pathogenesis of squamous cell carcinomas of the lung.
Yuan P; Kadara H; Behrens C; Tang X; Woods D; Solis LM; Huang J; Spinola M; Dong W; Yin G; Fujimoto J; Kim E; Xie Y; Girard L; Moran C; Hong WK; Minna JD; Wistuba II
PLoS One; 2010 Feb; 5(2):e9112. PubMed ID: 20161759
[TBL] [Abstract][Full Text] [Related]
7. Morphologic and clinicopathologic features of lung squamous cell carcinomas expressing Sox2.
Brcic L; Sherer CK; Shuai Y; Hornick JL; Chirieac LR; Dacic S
Am J Clin Pathol; 2012 Nov; 138(5):712-8. PubMed ID: 23086772
[TBL] [Abstract][Full Text] [Related]
8. SOX2 suppresses CDKN1A to sustain growth of lung squamous cell carcinoma.
Fukazawa T; Guo M; Ishida N; Yamatsuji T; Takaoka M; Yokota E; Haisa M; Miyake N; Ikeda T; Okui T; Takigawa N; Maeda Y; Naomoto Y
Sci Rep; 2016 Feb; 6():20113. PubMed ID: 26846300
[TBL] [Abstract][Full Text] [Related]
9. SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas.
Bass AJ; Watanabe H; Mermel CH; Yu S; Perner S; Verhaak RG; Kim SY; Wardwell L; Tamayo P; Gat-Viks I; Ramos AH; Woo MS; Weir BA; Getz G; Beroukhim R; O'Kelly M; Dutt A; Rozenblatt-Rosen O; Dziunycz P; Komisarof J; Chirieac LR; Lafargue CJ; Scheble V; Wilbertz T; Ma C; Rao S; Nakagawa H; Stairs DB; Lin L; Giordano TJ; Wagner P; Minna JD; Gazdar AF; Zhu CQ; Brose MS; Cecconello I; Ribeiro U; Marie SK; Dahl O; Shivdasani RA; Tsao MS; Rubin MA; Wong KK; Regev A; Hahn WC; Beer DG; Rustgi AK; Meyerson M
Nat Genet; 2009 Nov; 41(11):1238-42. PubMed ID: 19801978
[TBL] [Abstract][Full Text] [Related]
10. SOX2 and p63 colocalize at genetic loci in squamous cell carcinomas.
Watanabe H; Ma Q; Peng S; Adelmant G; Swain D; Song W; Fox C; Francis JM; Pedamallu CS; DeLuca DS; Brooks AN; Wang S; Que J; Rustgi AK; Wong KK; Ligon KL; Liu XS; Marto JA; Meyerson M; Bass AJ
J Clin Invest; 2014 Apr; 124(4):1636-45. PubMed ID: 24590290
[TBL] [Abstract][Full Text] [Related]
11. p63 and SOX2 Dictate Glucose Reliance and Metabolic Vulnerabilities in Squamous Cell Carcinomas.
Hsieh MH; Choe JH; Gadhvi J; Kim YJ; Arguez MA; Palmer M; Gerold H; Nowak C; Do H; Mazambani S; Knighton JK; Cha M; Goodwin J; Kang MK; Jeong JY; Lee SY; Faubert B; Xuan Z; Abel ED; Scafoglio C; Shackelford DB; Minna JD; Singh PK; Shulaev V; Bleris L; Hoyt K; Kim J; Inoue M; DeBerardinis RJ; Kim TH; Kim JW
Cell Rep; 2019 Aug; 28(7):1860-1878.e9. PubMed ID: 31412252
[TBL] [Abstract][Full Text] [Related]
12. Loss of Lkb1 and Pten leads to lung squamous cell carcinoma with elevated PD-L1 expression.
Xu C; Fillmore CM; Koyama S; Wu H; Zhao Y; Chen Z; Herter-Sprie GS; Akbay EA; Tchaicha JH; Altabef A; Reibel JB; Walton Z; Ji H; Watanabe H; Jänne PA; Castrillon DH; Rustgi AK; Bass AJ; Freeman GJ; Padera RF; Dranoff G; Hammerman PS; Kim CF; Wong KK
Cancer Cell; 2014 May; 25(5):590-604. PubMed ID: 24794706
[TBL] [Abstract][Full Text] [Related]
13. Chromosome 3q26 Gain Is an Early Event Driving Coordinated Overexpression of the PRKCI, SOX2, and ECT2 Oncogenes in Lung Squamous Cell Carcinoma.
Liu Y; Yin N; Wang X; Khoor A; Sambandam V; Ghosh AB; Fields ZA; Murray NR; Justilien V; Fields AP
Cell Rep; 2020 Jan; 30(3):771-782.e6. PubMed ID: 31968252
[TBL] [Abstract][Full Text] [Related]
14. SOX2 is an oncogene activated by recurrent 3q26.3 amplifications in human lung squamous cell carcinomas.
Hussenet T; Dali S; Exinger J; Monga B; Jost B; Dembelé D; Martinet N; Thibault C; Huelsken J; Brambilla E; du Manoir S
PLoS One; 2010 Jan; 5(1):e8960. PubMed ID: 20126410
[TBL] [Abstract][Full Text] [Related]
15. 14-3-3ζ/TGFβR1 promotes tumor metastasis in lung squamous cell carcinoma.
Zhao Y; Qiao W; Wang X; Yin H; Cui J; Cui Y; Chen X; Hu J; Lu H; Meng Q; Wang Y; Cai L
Oncotarget; 2016 Dec; 7(50):82972-82984. PubMed ID: 27764818
[TBL] [Abstract][Full Text] [Related]
16. SOX2 controls tumour initiation and cancer stem-cell functions in squamous-cell carcinoma.
Boumahdi S; Driessens G; Lapouge G; Rorive S; Nassar D; Le Mercier M; Delatte B; Caauwe A; Lenglez S; Nkusi E; Brohée S; Salmon I; Dubois C; del Marmol V; Fuks F; Beck B; Blanpain C
Nature; 2014 Jul; 511(7508):246-50. PubMed ID: 24909994
[TBL] [Abstract][Full Text] [Related]
17. CDK7 inhibition as a promising therapeutic strategy for lung squamous cell carcinomas with a SOX2 amplification.
Hur JY; Kim HR; Lee JY; Park S; Hwang JA; Kim WS; Yoon S; Choi CM; Rho JK; Lee JC
Cell Oncol (Dordr); 2019 Aug; 42(4):449-458. PubMed ID: 30838525
[TBL] [Abstract][Full Text] [Related]
18. Lkb1 inactivation drives lung cancer lineage switching governed by Polycomb Repressive Complex 2.
Zhang H; Fillmore Brainson C; Koyama S; Redig AJ; Chen T; Li S; Gupta M; Garcia-de-Alba C; Paschini M; Herter-Sprie GS; Lu G; Zhang X; Marsh BP; Tuminello SJ; Xu C; Chen Z; Wang X; Akbay EA; Zheng M; Palakurthi S; Sholl LM; Rustgi AK; Kwiatkowski DJ; Diehl JA; Bass AJ; Sharpless NE; Dranoff G; Hammerman PS; Ji H; Bardeesy N; Saur D; Watanabe H; Kim CF; Wong KK
Nat Commun; 2017 Apr; 8():14922. PubMed ID: 28387316
[TBL] [Abstract][Full Text] [Related]
19. Expression and role of the embryonic protein SOX2 in head and neck squamous cell carcinoma.
Schröck A; Bode M; Göke FJ; Bareiss PM; Schairer R; Wang H; Weichert W; Franzen A; Kirsten R; van Bremen T; Queisser A; Kristiansen G; Heasley L; Bootz F; Lengerke C; Perner S
Carcinogenesis; 2014 Jul; 35(7):1636-42. PubMed ID: 24743512
[TBL] [Abstract][Full Text] [Related]
20. SOX2 promotes tumor growth of esophageal squamous cell carcinoma through the AKT/mammalian target of rapamycin complex 1 signaling pathway.
Gen Y; Yasui K; Nishikawa T; Yoshikawa T
Cancer Sci; 2013 Jul; 104(7):810-6. PubMed ID: 23510069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
